11001674

Source:http://linkedlifedata.com/resource/pubmed/id/11001674

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0013089, umls-concept:C0025677, umls-concept:C0034656, umls-concept:C0042670, umls-concept:C0045093, umls-concept:C0205179, umls-concept:C0278828, umls-concept:C0282461, umls-concept:C1274040
pubmed:issue	17
pubmed:dateCreated	2000-9-19
pubmed:abstractText	Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) were compared in patients with locally advanced or metastatic transitional-cell carcinoma (TCC) of the urothelium.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/11001674-11181690
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Infective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating..., http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage..., http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0732-183X
pubmed:author	pubmed-author:AlbersPP, pubmed-author:BodrogiII, pubmed-author:CleallS PSP, pubmed-author:DogliottiLL, pubmed-author:HansenS WSW, pubmed-author:KerbratPP, pubmed-author:KnuthAA, pubmed-author:LippertC MCM, pubmed-author:MooreM JMJ, pubmed-author:OliverTT, pubmed-author:RobertsJ TJT, pubmed-author:RoychowdhuryD FDF, pubmed-author:Sanchez RoviraPP, pubmed-author:TomlinII, pubmed-author:Visseren-GrulC MCM, pubmed-author:WersallPP, pubmed-author:YonemitsuHH, pubmed-author:von der MaaseHH
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	3068-77
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11001674-Anti-Infective Agents, pubmed-meshheading:11001674-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11001674-Carcinoma, Transitional Cell, pubmed-meshheading:11001674-Cisplatin, pubmed-meshheading:11001674-Deoxycytidine, pubmed-meshheading:11001674-Doxorubicin, pubmed-meshheading:11001674-Female, pubmed-meshheading:11001674-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:11001674-Granulocyte-Macrophage Colony-Stimulating Factor, pubmed-meshheading:11001674-Hospitalization, pubmed-meshheading:11001674-Humans, pubmed-meshheading:11001674-Male, pubmed-meshheading:11001674-Methotrexate, pubmed-meshheading:11001674-Middle Aged, pubmed-meshheading:11001674-Neoplasm Metastasis, pubmed-meshheading:11001674-Neoplasm Staging, pubmed-meshheading:11001674-Prognosis, pubmed-meshheading:11001674-Quality of Life, pubmed-meshheading:11001674-Survival Analysis, pubmed-meshheading:11001674-Urinary Bladder Neoplasms, pubmed-meshheading:11001674-Vinblastine
pubmed:year	2000
pubmed:articleTitle	Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.
pubmed:affiliation	Aarhus University Hospital, Denmark. hvdm@oncology.dk
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III